BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 11134144)

  • 1. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
    Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism.
    Farnebo F; Enberg U; Grimelius L; Bäckdahl M; Schalling M; Larsson C; Farnebo LO
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3481-6. PubMed ID: 9329389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Ca-dependent change of serum PTH and extracellular Ca2+-sensing receptor expression in parathyroid adenoma.
    Kaneko C; Mizunashi K; Tanaka M; Uzuki M; Kikuchi M; Sawai T; Goto MM
    Calcif Tissue Int; 1999 Mar; 64(3):271-2. PubMed ID: 10024390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
    Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
    Kawata T; Imanishi Y; Kobayashi K; Kenko T; Wada M; Ishimura E; Miki T; Nagano N; Inaba M; Arnold A; Nishizawa Y
    Eur J Endocrinol; 2005 Oct; 153(4):587-94. PubMed ID: 16189180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
    Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone secretion after operation for primary hyperparathyroidism.
    Bergenfelz A; Nordén N; Ahrén B
    Surgery; 1993 Jun; 113(6):649-54. PubMed ID: 8506523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies.
    Juhlin C; Klareskog L; Nygren P; Ljunghall S; Gylfe E; Rastad J; Akerström G
    Endocrinology; 1988 Jun; 122(6):2999-3001. PubMed ID: 2836180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
    Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
    World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of the calcium-sensing receptor messenger RNA in parathyroid adenomas.
    Garner SC; Hinson TK; McCarty KS; Leight M; Leight GS; Quarles LD
    Surgery; 1997 Dec; 122(6):1166-75. PubMed ID: 9426434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenomatous human parathyroid cells exhibit impaired sensitivity to L-amino acids.
    Mun HC; Brennan SC; Delbridge L; Wilkinson M; Brown EM; Conigrave AD
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3567-74. PubMed ID: 19567535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma.
    Lu M; Berglund E; Larsson C; Höög A; Farnebo LO; Bränström R
    J Endocrinol; 2011 Jan; 208(1):31-9. PubMed ID: 20974637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve.
    Bas S; Aguilera-Tejero E; Bas A; Estepa JC; Lopez I; Madueño JA; Rodriguez M
    J Endocrinol; 2005 Jan; 184(1):241-7. PubMed ID: 15642800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-mediated parathyroid hormone release changes in patients treated with the calcimimetic agent cinacalcet.
    de Francisco AL; Izquierdo M; Cunningham J; Piñera C; Palomar R; Fresnedo GF; Amado JA; Unzueta MG; Arias M
    Nephrol Dial Transplant; 2008 Sep; 23(9):2895-901. PubMed ID: 18424820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of octreotide on release of intact 1-84 parathyroid hormone from human parathyroid cells.
    Sadler GP; Jones DL; Morgan JM; Neonakis E; Woodhead JS; Wheeler MH
    Br J Surg; 1998 Aug; 85(8):1133-7. PubMed ID: 9718014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
    Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
    Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of caveolin-1 and altered regulation of mitogen-activated protein kinase in cultured bovine parathyroid cells and human parathyroid adenomas.
    Kifor O; Kifor I; Moore FD; Butters RR; Cantor T; Gao P; Brown EM
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4455-64. PubMed ID: 12970324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiologic Changes in Extracellular pH Modulate Parathyroid Calcium-Sensing Receptor Activity and Secretion via a Histidine-Independent Mechanism.
    Campion KL; McCormick WD; Warwicker J; Khayat ME; Atkinson-Dell R; Steward MC; Delbridge LW; Mun HC; Conigrave AD; Ward DT
    J Am Soc Nephrol; 2015 Sep; 26(9):2163-71. PubMed ID: 25556167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans.
    Cañadillas S; Canalejo A; Santamaría R; Rodríguez ME; Estepa JC; Martín-Malo A; Bravo J; Ramos B; Aguilera-Tejero E; Rodríguez M; Almadén Y
    J Am Soc Nephrol; 2005 Jul; 16(7):2190-7. PubMed ID: 15888568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperparathyroidism: do perioperative biochemical variables correlate with parathyroid adenoma weight or volume?
    Randhawa PS; Mace AD; Nouraei SA; Stearns MP
    Clin Otolaryngol; 2007 Jun; 32(3):179-84. PubMed ID: 17550505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.